April 12, 2018 / 8:08 PM / in 3 months

BRIEF-Galapagos Announces Isabela Phase 3 Program In IPF

April 12 (Reuters) - Galapagos NV:

* GALAPAGOS ANNOUNCES ISABELA PHASE 3 PROGRAM IN IPF

* ANNOUNCES DESIGN OF A WORLDWIDE PHASE 3 PROGRAM TO EVALUATE GLPG1690 IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS

* GLOBAL PHASE 3 PROGRAM IS EXPECTED TO CONSIST OF TWO IDENTICALLY DESIGNED TRIALS, ISABELA 1 AND ISABELA 2

* PHASE 3 PROGRAM IS EXPECTED TO START DOSING IN SECOND HALF OF 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below